At Spectrum Pharmaceuticals, Inc., we bring the expertise and passion for excellence of our team to acquire, develop and commercialize novel and targeted pharmaceuticals for unmet medical needs while building value for our shareholders.
Location: United States, Nevada, Henderson
Employees: 51-200
Founded date: 2002
Investors 2
| Date | Name | Website |
| - | Aisling Ca... | aislingcap... |
| 16.09.2022 | Checkmate ... | checkmatec... |
Mentions in press and media 4
| Date | Title | Description |
| 11.03.2021 | FDA Grants Fast Track Designation to Spectrum Pharmaceuticals’ Poziotinib | HENDERSON, Nev.--(BUSINESS WIRE)--Mar 11, 2021-- Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced that the U.S. Food and Drug Administration (FDA) has g... |
| 26.02.2021 | Spectrum Pharmaceuticals Announces Poster Presentation at Upcoming Miami Breast Cancer Conference | HENDERSON, Nev.--(BUSINESS WIRE)--Feb 26, 2021-- Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced a poster presentation on interim safety evaluation of ... |
| - | Spectrum Pharmaceuticals Presents Twice Daily Dosing Data for Poziotinib at the ESMO TAT Virtual Congress 2021 | HENDERSON, Nev.--(BUSINESS WIRE)--Mar 2, 2021-- Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today presented results from Cohort 3 and initial twice daily (BID) dos... |
| - | Spectrum Pharmaceuticals Provides Update on ROLONTIS® (eflapegrastim) Pre-Approval Inspection | HENDERSON, Nev.--(BUSINESS WIRE)--Mar 16, 2021-- Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced that the U.S. Food and Drug Administration (FDA) has s... |